Zevra Therapeutics, Inc. Capital Leased Assets, Gross
Zevra Therapeutics, Inc. (ZVRA) had Capital Leased Assets, Gross of $1.02 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Leases
us-gaap:CapitalLeasedAssetsGross · last filed 2019-03-01
- 2018-12-31: Capital Leased Assets, Gross $1.02M.
- 2017-12-31: Capital Leased Assets, Gross $966.00K.
- 2016-12-31: Capital Leased Assets, Gross $867.00K.
- 2015-12-31: Capital Leased Assets, Gross $94.00K.
| Period end | Capital Leased Assets, Gross |
|---|---|
| 2018-12-31 | $1.02M 10-K · filed 2019-03-01 |
| 2017-12-31 | $966.00K 10-K · filed 2019-03-01 |
| 2016-12-31 | $867.00K 10-K · filed 2018-03-30 |
| 2015-12-31 | $94.00K 10-K · filed 2017-03-10 |
| 2014-12-31 | $94.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |